featured
featured Articles
Here's a look at smaller cap companies that could very well offer patient investors some huge returns for the rest of 2023 and beyond.
Published:
The stock market has been unforgiving to the oil sector so far in 2020. Many investors are puzzled by the lack of interest and outright disdain that the stock market has for the top energy stocks.
Published:
Kroger is scheduled to release its fiscal fourth-quarter financial results before the markets open on Thursday, and analysts are looking for solid year-over-year growth.
Published:
Silver is supposed to be correlated to gold, so it should be rising by close to the same amount. Yet, there has been a disparity in the metals market.
Published:
Dollar Tree reported mixed fiscal third-quarter results and guidance below expectations before markets opened Tuesday.
Published:
Nordstrom released disappointing fiscal fourth-quarter financial results after markets closed Thursday.
Published:
Ranging from very conservative to aggressive, these Raymond James health care stock picks are good additions to long-term portfolios looking to add or increase exposure to the sector.
Published:
Mall traffic continues to dwindle. That leaves retailers with many of their locations in these buildings in major trouble. None is troubled so much already as J.C. Penney.
Published:
Wall Street did not like Nordstrom's results. It also should not like its insistence that physical stores are the wave of the future.
Published:
Supply chain concerns may impact its stock, but with a dominant position in the memory chip market, Micron Technology most likely will come out of this as a leader.
Published:
Co-Diagnostics is a small-cap stock that is far from a household name, but it has received much added exposure of late.
Published:
These four top stocks have paid consistent and rising dividends for years, and they are good choices for investors with a higher risk tolerance who are seeking income, especially after their share...
Published:
Canadian cannabis stocks have performed poorly, in due to the sharp drop in share prices that marijuana stocks suffered last year. Yet, Organigram seemed to be positioned for a better year in fiscal...
Published:
